Clinical Trial Update: Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Rec-LH PD in men with acquired hypogonadotropic hypogonadism, focusing on safety and pharmacodynamics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hypogonadotropic Hypogonadism

Drugs mentioned

• Rec-LH PD

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Acquired Hypogonadotropic Hypogonadism | Phase 2 | Status: UNKNOWN